Resource Library
Showing 1 to 10 of 34 results
You or your loved one has been diagnosed with a type of blood cancer. Cancer treatment can be complex, with different types of treatment options available for some blood cancers. What are they and how do they work? This fact sheet will help you Learn about the different treatment options available, Understand each type of treatment and how it can help,…
In this 1-hour recorded webcast, hematologist-oncologist at the Princess Margaret Cancer Centre in Toronto, and DLBCL researcher, Dr. John Kuruvilla, discusses diagnosis and approach to managing and treating DLBCL, the most commonly diagnosed subtype of non-Hodgkin lymphoma.
Lymphoplasmacytic lymphoma (LPL) and its related condition, Waldenström macroglobulinemia (WM), are slow-growing subtypes of non-Hodgkin lymphoma.
SMZL is a rare, slow-growing (indolent) B-cell subtype of non-Hodgkin lymphoma. SMZL is one of three subtypes of marginal zone lymphoma, and it often involves the spleen, bone marrow, blood, and abdomen.
Your treatment plan for DLBCL will be based on your age and overall health, potential long-term side effects, your stage (where the disease is located in you), symptoms, and fertility if applicable. Types of treatment for DLBCL include traditional chemotherapies, targeted therapies, stem cell transplant, radiation, and immunotherapies.
A type of non-Hodgkin lymphoma, diffuse large B-cell lymphoma (DLBCL) involves the B-cells that help to fight off infection, can grow quickly (aggressive) or slowly (indolent), can happen at any age but most often appears in middle age or older, and usually has no known cause.
The C Word. When Kids get Cancer presentation. A comprehensive document explaining cancer to children. For use in the school or at home.
“The majority of people with DLBCL will be cured with their first treatment – so that's a success story,” says Dr. John Kuruvilla, working as a hematologist-oncologist for 20 years including as a researcher in DLBCL, which is the largest form of non-Hodgkin lymphoma.
“Researchers are now focused on maintaining an excellent cure rate and…
“Researchers are now focused on maintaining an excellent cure rate and…
In this 1-hour presentation, Dr. Abi.Vijenthira, hematologist at Princess Margaret Cancer Centre in Toronto, provided an overview of the approach to non-Hodgkin lymphomas, and provided updates on recent developments in the management of these lymphomas.
In this 1-hour presentation, Dr. Mary-Margaret Keating, hematologist at the QEII Health Sciences Centre in Halifax, NS, provided an overview of the approach to Hodgkin lymphoma and updates on recent developments in the management of this lymphoma.